IQVIA Holdings Inc (IQV)

Industry Diagnostics & Research

This stock can be held in an Investment ISA and an Investment Account
Sell

$145.00

Buy

$155.00

arrow-down$-4.30 (-2.81%)

IQVIA Holdings Inc is an information and technology-enabled healthcare service provider to the pharmaceutical services, biotechnology, and healthcare industries. The Commercial Solutions and Research and Development Solutions generate maximum revenue.
Prices updated at 10 May 2025, 00:10 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Mr. Ari Bousbib
CEO
Mr. Ari Bousbib
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
89,000
Head office
2400 Ellis Road
Durham
United States
27703
mobile
+1 919 998-2000
letter
ir@iqvia.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Ari Bousbib
Chairman of the Board and Chief Executive Officer
1.80m--26.73m-
Mr. John G. Danhakl
Independent Director
0.12m--0.36m-
Ms. Colleen A. Goggins
Independent Director
0.14m--0.38m-
Mr. Eric M. Sherbet
Executive Vice President, General Counsel and Secretary
0.65m--4.17m-
Ms. Carol J. Burt
Independent Director
0.14m--0.38m-
Mr. Ronald E. Bruehlman
Executive Vice President and Chief Financial Officer
0.91m--8.37m-
Mr. Todd B. Sisitsky
Independent Director
-----
Dr. John M. Leonard, M.D.
Lead Independent Director
0.17m--0.41m-
Ms. Sheila A. Stamps
Independent Director
0.12m--0.35m-
Mr. James A. Fasano
Independent Director
0.14m--0.38m-
Ms. Leslie Wims Morris
Independent Director
0.11m--0.35m-
Ms. Keriann Cherofsky
Senior Vice President, Chief Accounting Officer and Corporate Controller
-----
Mr. W. Richard Staub, III
President, Research and Development Solutions
-----
Mr. Bhavik Patel
President, Commercial Solutions
0.45m--3.01m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc20,131,7340.068911055040.52682930 Apr 202511.64
BlackRock Inc15,503,7420.061653369392.22155630 Apr 20258.96
Harris Associates L.P.11,335,6772.93126115657311.36222830 Apr 20256.55
State Street Corp7,880,7570.06111160691.49483130 Apr 20254.56
BlackRock Fund Advisors6,108,3238.6089-185312-30 Apr 20253.53

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
03 Dec 2024-Mr. John G. Danhakl200.58255,7401,275--
05 Feb 2025-Mr. John G. Danhakl205.4429,9942,269--
06 Nov 2024-Mr. John G. Danhakl221.2529,8692,123--
06 Nov 2024-Ms. Colleen A. Goggins221.2534,9583,948--
06 Nov 2024-Mr. James A. Fasano221.2534,9581,676--
06 Nov 2024-Ms. Leslie Wims Morris221.2527,4352,547--
27 Aug 2024-Mr. Eric M. Sherbet246.33320,22919,536--
28 Jul 2024-Ms. Keriann Cherofsky239.678,388753--
28 Jul 2024-Mr. Bhavik Patel239.6719,893545--
18 Jul 2024-Mr. John G. Danhakl224.8530,1301,988--
18 Jul 2024-Ms. Colleen A. Goggins224.8535,0773,790--
18 Jul 2024-Mr. James A. Fasano224.8534,8521,518--
18 Jul 2024-Ms. Leslie Wims Morris224.8527,6572,423--
07 May 2024-Mr. John P. Connaughton--1,047--
07 May 2024-Ms. Carol J. Burt229.14239,9101,047--
07 May 2024-Dr. John M. Leonard, M.D.--13,783--
07 May 2024-Ms. Sheila A. Stamps229.14239,9101,047--
01 Mar 2024-Mr. Ari Bousbib250.054,066,063812,169--
01 Mar 2024-Mr. Ari Bousbib249.972,791,915785,583--
01 Mar 2024-Mr. Ari Bousbib251.033,870,130796,752--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.